|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/39 | |
| C07K 16/12 | |||
| A61K 39/09 |
| (11) | Number of the document | 2827899 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13710422.0 |
| Date of filing the European patent application | 2013-03-19 | |
| (97) | Date of publication of the European application | 2015-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/055719 |
| Date | 2013-03-19 |
| (87) | Number | WO 2013/139803 |
| Date | 2013-09-26 |
| (30) | Number | Date | Country code |
| PCT/EP2012/0548 | 2012-03-19 | WO | |
| PCT/EP2012/0022 | 2012-05-26 | WO |
| (72) |
SEEBERGER, Peter H., DE
STALLFORTH, Pierre, DE
DE LIBERO, Gennaro, CH
CAVALLARI, Marco, CH
|
| (73) |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,
Hofgartenstrasse 8, 80539 München,
DE
Universitätsspital Basel, Hebelstrasse 32, 4031 Basel, CH |
| (54) | POLYSACCHARIDE ANTIGEN-GLYCOLIPID CONJUGATE VACCINES |
| POLYSACCHARIDE ANTIGEN-GLYCOLIPID CONJUGATE VACCINES |